Do you want to read an article? Please log in or register.
Fabry disease: development and progression of left ventricular hypertrophy despite long-term enzyme replacement therapy
Heart, Artery and Coronary Diseases
Related content
Heart, Artery and Coronary DiseasesVentricular Function
Recovery of Left Ventricular Function and Long-Term Outcomes in Patients With Takotsubo Syndrome
J Am Coll Cardiol
Almendro-Delia M, López-Flores L, Uribarri A, Vedia O, Blanco-Ponce E, López-Flores MDC, Rivas-García AP, Fernández-Cordón C, Sionis A, Martín-García AC, Vazirani R, Corbí-Pascual M, Salamanca J, Pérez-Castellanos A, Martínez M, Becerra VM, Aritza-Conty D, López-País J, Guillén-Marzo M, Lluch-Requerey C, García-Rubira JC, Núñez-Gil IJ, RETAKO Investigators
doi: 10.1016/j.jacc.2024.05.075
RECOMMENDED
Cardiovascular Risk and Diseases
Long-Term Changes to Cardiovascular Biomarkers After Hormone Therapy in the Women's Health Initiative Hormone Therapy Clinical Trials
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Obstet Gynecol
Nudy M, Aragaki AK, Jiang X, Manson JE, Shadyab AH, Jung SY, Martin LW, Wild RA, Womack C, Mouton CP, Rossouw JE, Schnatz PF
doi: 10.1097/AOG.0000000000005862
RECOMMENDED
Hypertension
Left Ventricular Hypertrophy in Women With a History of Preeclampsia
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Hypertension
Hauge MG, Damm P, Kofoed KF, Møller ELR, Lopez AG, Ersbøll AS, Johansen M, Sigvardsen PE, Pham MHC, Goetze JP, Fuchs A, Kühl JT, Nordestgaard BG, Køber LV, Gustafsson F, Linde JJ
doi: 10.1161/HYPERTENSIONAHA.124.23497
Heart, Artery and Coronary Diseases
Decreased Left Ventricular Systolic Function during the Late Phase after Response to Cardiac Resynchronization Therapy
Heart Rhythm
Iwawaki T, Inden Y, Yanagisawa S, Miyamae K, Miyazawa H, Goto T, Kondo S, Tachi M, Shimojo M, Tsuji Y, Murohara T
doi: 10.1016/j.hrthm.2025.02.002
Heart, Artery and Coronary DiseasesTherapy and Intervention
The impact of elevated C-reactive protein levels on long-term outcomes of patients undergoing transcatheter aortic valve replacement
Cardiovasc Revasc Med
Brunner S, Moccetti F, Loretz L, Conrad N, Bossard M, Attinger-Toller A, Kurmann R, Cuculi F, Wolfrum M, Toggweiler S
doi: 10.1016/j.carrev.2024.07.002
Heart, Artery and Coronary Diseases
Long-term prognostic value of contemporary stress echocardiography in patients with suspected or known coronary artery disease: systematic review and meta-analysis
Heart
Ihekwaba U, Johnson N, Choi JS, Savarese G, Orsini N, Khoo J, Squire I, Kardos A
doi: 10.1136/heartjnl-2024-324534
Heart, Artery and Coronary DiseasesTherapy and Intervention
Mortality after cardiac resynchronization therapy or right ventricular pacing in transcatheter aortic valve replacement recipients
Clin Res Cardiol
Kirchner J, Gerçek M, Sciacca V, Reil JC, Guckel D, Potratz M, Omran H, Friedrichs K, Eitz T, Bleiziffer S, Schramm R, Imnadze G, Sohns C, Gummert J, Rudolph V, Rudolph TK, Sommer P, Fink T
doi: 10.1007/s00392-024-02450-1
Heart, Artery and Coronary Diseases
Impact of Early Bleeding on Long-Term Mortality Following Left Atrial Appendage Occlusion
Heart Rhythm
Lo Russo GV, Kara Balla A, Alarouri H, Liu CH, Zhour Adi M, Killu AM, Alkhouli M
doi: 10.1016/j.hrthm.2024.07.028
Heart, Artery and Coronary Diseases
Hospitalized upper extremity artery disease patients: treatment and long-term outcomes
Eur Heart J
Makowski L, Engelbertz C, Köppe J, Dröge P, Ruhnke T, Günster C, Gerß J, Freisinger E, Malyar N, Reinecke H, Feld J
doi: 10.1093/eurheartj/ehae904